89 related articles for article (PubMed ID: 14715247)
1. Androgen suppresses PML protein expression in prostate cancer CWR22R cells.
Yang L; Yeh SD; Xie S; Altuwaijri S; Ni J; Hu YC; Chen YT; Bao BY; Su CH; Chang C
Biochem Biophys Res Commun; 2004 Jan; 314(1):69-75. PubMed ID: 14715247
[TBL] [Abstract][Full Text] [Related]
2. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.
Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG
Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
Komura N; Asakawa M; Umezawa K; Segawa K
Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
[TBL] [Abstract][Full Text] [Related]
5. PML is required for homeodomain-interacting protein kinase 2 (HIPK2)-mediated p53 phosphorylation and cell cycle arrest but is dispensable for the formation of HIPK domains.
Möller A; Sirma H; Hofmann TG; Rueffer S; Klimczak E; Dröge W; Will H; Schmitz ML
Cancer Res; 2003 Aug; 63(15):4310-4. PubMed ID: 12907596
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.
Esmaeili M; Jennek S; Ludwig S; Klitzsch A; Kraft F; Melle C; Baniahmad A
J Mol Cell Biol; 2016 Jun; 8(3):207-20. PubMed ID: 26993046
[TBL] [Abstract][Full Text] [Related]
7. The function of PML in p53-dependent apoptosis.
Guo A; Salomoni P; Luo J; Shih A; Zhong S; Gu W; Pandolfi PP
Nat Cell Biol; 2000 Oct; 2(10):730-6. PubMed ID: 11025664
[TBL] [Abstract][Full Text] [Related]
8. The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer.
Fizazi K; Martinez LA; Sikes CR; Johnston DA; Stephens LC; McDonnell TJ; Logothetis CJ; Trapman J; Pisters LL; Ordoñez NG; Troncoso P; Navone NM
Clin Cancer Res; 2002 Mar; 8(3):775-81. PubMed ID: 11895908
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated expression of PML suppresses growth and tumorigenicity of prostate cancer cells.
He D; Mu ZM; Le X; Hsieh JT; Pong RC; Chung LW; Chang KS
Cancer Res; 1997 May; 57(10):1868-72. PubMed ID: 9157977
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of the cyclin-dependent kinase inhibitor p21 by PML/RARalpha.
Yang WL; Zeng YX; El-Deiry WS; Nason-Burchenal K; Dmitrovsky E; Chin KV
Mol Cell Biol Res Commun; 1999 May; 1(2):125-31. PubMed ID: 10356361
[TBL] [Abstract][Full Text] [Related]
11. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer.
Zhang H; Melamed J; Wei P; Cox K; Frankel W; Bahnson RR; Robinson N; Pyka R; Liu Y; Zheng P
Cancer Immun; 2003 Feb; 3():2. PubMed ID: 12747744
[TBL] [Abstract][Full Text] [Related]
12. Altered corepressor SMRT expression and recruitment to target genes as a mechanism that change the response to androgens in prostate cancer progression.
Godoy AS; Sotomayor PC; Villagran M; Yacoub R; Montecinos VP; McNerney EM; Moser M; Foster BA; Onate SA
Biochem Biophys Res Commun; 2012 Jul; 423(3):564-70. PubMed ID: 22695118
[TBL] [Abstract][Full Text] [Related]
13. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
14. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
Lin J; Tang H; Jin X; Jia G; Hsieh JT
Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
[TBL] [Abstract][Full Text] [Related]
15. p53 overexpression represses androgen-mediated induction of NKX3.1 in a prostate cancer cell line.
Jiang A; Yu C; Zhang P; Chen W; Liu W; Hu X; Zhang J
Exp Mol Med; 2006 Dec; 38(6):625-33. PubMed ID: 17202838
[TBL] [Abstract][Full Text] [Related]
16. Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line.
Jiang WQ; Szekely L; Klein G; Ringertz N
Exp Cell Res; 1996 Dec; 229(2):289-300. PubMed ID: 8986612
[TBL] [Abstract][Full Text] [Related]
17. Regulation of p53 activity in nuclear bodies by a specific PML isoform.
Fogal V; Gostissa M; Sandy P; Zacchi P; Sternsdorf T; Jensen K; Pandolfi PP; Will H; Schneider C; Del Sal G
EMBO J; 2000 Nov; 19(22):6185-95. PubMed ID: 11080164
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions.
Wu WS; Xu ZX; Ran R; Meng F; Chang KS
Oncogene; 2002 May; 21(24):3925-33. PubMed ID: 12032831
[TBL] [Abstract][Full Text] [Related]
19. Promyelocytic leukemia protein is required for gain of function by mutant p53.
Haupt S; di Agostino S; Mizrahi I; Alsheich-Bartok O; Voorhoeve M; Damalas A; Blandino G; Haupt Y
Cancer Res; 2009 Jun; 69(11):4818-26. PubMed ID: 19487292
[TBL] [Abstract][Full Text] [Related]
20. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
